register

News & Trends - Pharmaceuticals

Medicines Australia calls for a focus in planning Australia’s future in health

Health Industry Hub | August 4, 2020 |

Pharma News: Medicines Australia Chief Executive Officer, Elizabeth de Somer has urged a focus on planning for the future – reviewing and adopting the COVID-19 lessons being learnt and working now on setting up Australia and the world for the next pandemic/health crisis.

Speaking on Radio National’s Sunday Roundtable on Vaccine Diplomacy with Julian Morrow, Ms de Somer reiterated that while we remain in challenging times managing the current COVID-19 pandemic, there is a critical need for us to seize the opportunity to adopt a future view and set ourselves up and prepare for the next health challenge.

“What is important now is while we are enduring the extreme events of COVID-19, and engaged in a collaborate search for an effective vaccine, it’s critical for us to start to plan ahead essentially for our next health event or another pandemic. We need to take on the experiences we are gathering and lessons we are learning now and strengthen our health capabilities for the future,” said Ms de Somer.

“A strong innovative position on health and a robust local industry here is a critical part of this, including clinical trial capabilities to ensure we have a very firm foundation to support local needs but also generate a solid contribution and footprint on the global stage.

“Never before has the nation’s health and economic wealth been more closely linked. Ensuring innovative healthcare delivery and solutions remains a central priority moving forward will be essential to support Australia’s road to economic recovery.

“There are currently over 165 vaccines are in research and development around the world and 27 vaccines are now in human trials.  The innovative industry is playing a very central role in vaccine development actively progressing with trial programs and setting up the large-scale manufacturing needed to support the volumes of vaccines required.

“Above everything else, ongoing collaboration, at both a global and local level, will need to be maintained. We must continue to work together now to address this unprecedented global health crisis but also to plan and prepare for the future.  The firm lessons we are learning now must ensure we build a stronger and more resilient path ahead,” concluded Ms de Somer.


News & Trends - Pharmaceuticals

Medicines Australia and AusBiotech join Research Australia and DHCRC in welcoming funding for medical research and One Stop Shop

Medicines Australia and AusBiotech join Research Australia and Digital Health CRC in welcoming funding of national strategy for medical research and National One Stop Shop

Health Industry Hub | May 2, 2024 |

Pharma News: Medicines Australia, AusBiotech, Research Australia and the Digital Health Cooperative Research Centre (DHCRC) applaud the funding announcement of […]

More


News & Trends - MedTech & Diagnostics

Health insurers clash with government decision on GUIs, prompting threat of premium hikes

Health insurers clash with government on GUIs decision, prompting threat of premium hikes

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A warning of potential increases in health insurance premiums for 15 million Australians has been issued […]

More


News & Trends - MedTech & Diagnostics

Catheter ablation underused in atrial fibrillation despite proven efficacy

Catheter ablation underused in atrial fibrillation despite proven efficacy

Health Industry Hub | May 2, 2024 |

MedTech & Diagnostics News: A new study highlights that nearly half of all patients hospitalised for atrial fibrillation (AF) in […]

More


News & Trends - Biotechnology

How prepared are we for the next pandemic?

How prepared are we for the next pandemic?

Health Industry Hub | May 2, 2024 |

Biotech News: The Melbourne biotechnology community came together for a symposium hosted by BioMelbourne and mRNA Victoria, featuring specialists in […]

More


This content is copyright protected. Please subscribe to gain access.